Product Categories
Country: | China |
---|---|
Tel: | 021-54306202 |
Mobile: | 18917919676 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
(Ala11·22·2)-VIP (human, mouse, rat) trifluoroacetate salt | C139H231N43O39S | 291524-04-4 | Details |
(Lys8)-Vasotocin (free acid) | C43H66N12O13S2 | Details |
Ac-Ala-Ala-Ala-pNA | C17H23N5O6 | 40817-33-2 | Details |
4-Abz-Gly-Pro-D-Leu-D-Ala-NHOH trifluoroacetate salt | C23H34N6O6 | 124168-73-6 | Details |
(Pyr16)-VIP (16-28) (chicken) | C67H113N17O18S | 73073-47-9 | Details |
Ac-Ala-Ala-Ala-Ala-OMe | C15H26N4O6 | 30802-29-0 | Details |
WWamide-3 | C46H66N12O9S | 149636-89-5 | Details |
(d(CH)1,Tyr(Me)2,Thr,Orn,des-Gly-NH)-Vasotocin trifluoroacetate salt | C45H69N9O12S2 | 115499-13-3 | Details |
Ac-Arg-Ser-Leu-Lys-AMC trifluoroacetate salt | C33H51N9O8 | 259176-76-6 | Details |
VIP sulfoxide (human, mouse, rat) trifluoroacetate salt | C147H238N44O43S | 95050-90-1 | Details |
(Cys935)-Focal Adhesion Kinase 1 (921-935) amide (human) | Details |
VIP Receptor-Binding Inhibitor L-8-K trifluoroacetate salt | C50H77N9O12S | 120550-85-8 | Details |
Ac-Ala-Ala-Tyr-AMC | C27H30N4O7 | 99590-93-9 | Details |
(d(CH)1,D-Phe2,Ile,Ala-NH)-Vasopressin | C53H77N13O10S2 | 99835-78-6 | Details |
Abz-Gln-Val-Val-Ala-Gly-Ala-EDDnp trifluoroacetate salt | C38H54N12O12 | 152390-52-8 | Details |
Prepro VIP (81-122) (human) | 111366-38-2 | Details |
VIP (6-28) (human, mouse, rat) trifluoroacetate salt | C126H207N37O34S | 69698-54-0 | Details |
(H-Cys-Val-OH) (Disulfide bond) | C16H30N4O6S2 | 21141-84-4 | Details |
(Arg)-Vasotocin acetate salt | C43H67N15O12S2 | 113-80-4 | Details |
Ac-Ala-Ala-Ala-OMe | C12H21N3O5 | 26910-17-8 | Details |
(H-Gly-Cys-OH) (Disulfide bond) | C10H18N4O6S2 | 26798-52-7 | Details |
Ac-Ala-Ala-Ala-Ala-OH | C14H24N4O6 | 15483-58-6 | Details |
VIP (guinea pig) trifluoroacetate salt | C147H239N43O42S2 | 96886-24-7 | Details |
Ac-Arg-Cys-Met-5-aminopentanoyl-Arg-Val-Tyr-5-aminopentanoyl-Cys-NH trifluoroacetate salt (Disulfide bond) | C49H82N16O11S3 | 353487-64-6 | Details |
Abz-Gly-Ile-Val-Arg-Ala-Lys(Dnp)-OH | C41H61N13O12 | 827044-38-2 | Details |
Abz-Glu-Ile-Phe-Val-Phe-Lys-Gln-ethylenediamine-Dnp | C60H80N14O15 | 848491-08-7 | Details |
VIP (10-28) (human, bovine, porcine, rat) | C105H180N32O26S | 69856-17-3 | Details |
(d(CH)1,D-Tyr(Et)2,Val,Arg,des-Gly)-Vasopressin | C51H74N12O10S2 | 90332-82-4 | Details |
H-His-Leu-Pro-Pro-Pro-Val-His-Leu-Pro-Pro-Pro-Val-OH | C64H98N16O13 | 154244-49-2 | Details |
Abz-Ala-Phe-Ala-Phe-Asp-Val-Phe-3-nitro-Tyr-Asp-OH trifluoroacetate salt | C62H71N11O18 | 143147-74-4 | Details |
H-His-Leu-Pro-Pro-Pro-Val-OH | C32H50N8O7 | 121305-29-1 | Details |
(d(CH)1,D-Ile2,Ile,Arg)-Vasopressin | C49H77N13O10S2 | 88686-53-7 | Details |
(H-Cys-Tyr-OH) (Disulfide bond) | C24H30N4O8S2 | 7369-94-0 | Details |
Ac-Phe-Tyr-OH | C20H22N2O5 | 2365-53-9 | Details |
(Deamino-Cys1,D-Orn)-Vasopressin | C45H62N12O12S2 | 60498-04-6 | Details |
Xenopsin-Related Peptide 1 (XP-1) | C51H79N15O9 | 117442-28-1 | Details |
Ac-Ala-Ala-OMe | C9H16N2O4 | 30802-26-7 | Details |
(d(CH)1,Tyr(Me)2,Thr,Orn,Tyr-NH)-Vasotocin trifluoroacetate salt | C54H79N11O13S2 | 114056-26-7 | Details |
(H-Cys-Gly-OH) (Disulfide bond) | C10H18N4O6S2 | 7729-20-6 | Details |
(Cys(Acm)33)-Endostatin (6-49) (human) | Details |
(D-Phe2)-VIP (human, mouse, rat) | C153H242N44O41S | 104051-15-2 | Details |
(Deamino-Cys1,β-cyclohexyl-Ala,Arg)-Vasopressin trifluoroacetate salt | C50H71N13O11S2 | 500170-27-4 | Details |
H-D-Ala-D-Ala-D-Ala-D-Ala-D-Ala-D-Ala-OH | C18H32N6O7 | 286842-36-2 | Details |
(d(CH2)51,D-Tyr(Me)2,Val4,Arg8)-Vasopressin | C52H75N13O11S2 | Details |
(β-Asp3)-VIP (human, bovine, porcine, rat) | Details |
Xenopsin-Related Peptide 2 (XP-2) trifluoroacetate salt | C60H88N16O10 | 117442-29-2 | Details |
Prepro VIP (111-122) (human) | C53H87N13O21 | 123025-94-5 | Details |
Abz-Ala-Gly-Leu-Ala-p-nitrobenzylamide | C28H37N7O7 | 100307-95-7 | Details |
Ac-Ala-Ala-Ser(POH)-Pro-Arg-pNA trifluoroacetate salt | C28H43N10O12P | 202739-37-5 | Details |
Ac-Ala-Ala-Pro-Ala-AMC | C26H33N5O7 | 62037-45-0 | Details |
(H-Cys-Leu-OH) (Disulfide bond) | C18H34N4O6S2 | 21141-85-5 | Details |
6-(7-Nitro-benzo[2,1,3]oxadiazol-4-ylamino)-hexanoyl-Arg-Pro-Lys-Pro-Leu-Ala-Nva-Trp-Lys((7-dimethylaminocoumarin-4-yl)-acetyl)-NH trifluoroacetate salt | C78H111N21O16 | 945414-97-1 | Details |
(p-Chloro-D-Phe,Leu1)-VIP (human, mouse, rat) trifluoroacetate salt | C148H239ClN44O42 | 102805-45-8 | Details |
(d(CH)1,Tyr(Me)2,Arg)-Vasopressin trifluoroacetate salt | C52H74N14O12S2 | 73168-24-8 | Details |
Ac-Ala-Gln-Ala-pNA | C19H26N6O7 | 201677-60-3 | Details |
Biotinyl-VIP (human, mouse, rat) trifluoroacetate salt | C157H252N46O44S2 | 1815618-13-3 | Details |
(d(CH)1,Tyr(Et)2,Val,Arg,des-Gly)-Vasopressin trifluoroacetate salt | C51H74N12O10S2 | 90332-81-3 | Details |
H-Ala-Ala-Ala-Ala-Glu-Glu-Glu-Glu-Glu-OH | C37H57N9O20 | Details |
H-D-ALA-GLY-OH | C5H10N2O3 | 3997-90-8 | Details |
WWamide-2 | C46H65N13O10S | 149636-88-4 | Details |
Ac-Ala-Ala-Pro-Ala-pNA | C22H30N6O7 | 96699-74-0 | Details |
(Gly106)-Cytochrome C (92-107) (Manduca sexta) | C77H129N23O24 | 213260-63-0 | Details |
PHM-27 (human) trifluoroacetate salt | C135H214N34O40S | 87403-73-4 | Details |
Abz-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH trifluoroacetate salt | C50H77N17O13 | 290362-09-3 | Details |
Ac-Ala-Leu-Cys-Asp-Asp-Pro-Arg-Val-Asp-Arg-Trp-Tyr-Cys-Gln-Phe-Val-Glu-Gly-NH (Disulfide bond) | C97H139N27O29S2 | 1926163-13-4 | Details |
Ac-Ala-Ala-Ala-OH | C11H19N3O5 | 19245-85-3 | Details |
(Gln3)-Connexin 37 (51-58) (human, mouse, rat) | C40H59N11O15 | 155893-22-4 | Details |
Xenin 25 | C139H224N38O32S | 144092-28-4 | Details |
Abz-Phe-Arg-Lys(Dnp)-Pro-OH hydrochloride salt | C39H49N11O10 | 500799-61-1 | Details |
(H-Glu(Cys-βNA)-OH)2 | C36H40N6O8S2 | 201990-68-3 | Details |
(d(CH)1,D-Ile2,Ile,Arg,Ala-NH)-Vasopressin | C50H79N13O10S2 | 114455-29-7 | Details |
Abz-Gly-Ala-Ala-Pro-Phe-3-nitro-Tyr-Asp-OH trifluoroacetate salt | C42H49N9O14 | 142689-23-4 | Details |
Xenopsin (XP) | C47H73N13O10 | 51827-01-1 | Details |
Ac-Ala-Ala-Pro-Val-pNA | C24H34N6O7 | 133261-53-7 | Details |
RF9 trifluoroacetate salt | C26H38N6O3 | 876310-60-0 | Details |
(Pyr1)-VIP (16-28) (human, mouse, rat) | C68H114N18O18S | 134907-86-1 | Details |
Ac-Ala-Ala-Phe-OMe | C18H25N3O5 | 50395-42-1 | Details |
WWamide-1 | C46H65N11O10S | 149665-72-5 | Details |
PHI-27 (rat) | C136H216N36O41 | 96849-38-6 | Details |
Ac-Arg-Leu-Arg-AMC trifluoroacetate salt | C30H46N10O6 | 929903-87-7 | Details |
4-Biphenylac-Cys(Me)-D-Arg-Phe-(2-phenylethyl)amide | C41H49N7O4S | 478164-48-6 | Details |
(Deamino-Cys1,Leu,Lys)-Vasopressin trifluoroacetate salt | C47H67N11O11S2 | 42061-33-6 | Details |
(d(CH)1,Tyr(Et)2,Val,Arg,des-Gly-NH)-Vasopressin | C51H73N11O11S2 | 110567-67-4 | Details |
Ac-Ala-Pro-Ala-pNA | C19H25N5O6 | 61596-39-2 | Details |
(N-Me-Lys3)-Xenopsin (3-8) | C35H56N10O6 | Details |
H-Phe-Phe-OH | C18H20N2O3 | 2577-40-4 | Details |
Abz-Ser-Pro-3-nitro-Tyr-OH | C24H27N5O9 | 553644-01-2 | Details |
PHI-27 (porcine) | C136H216N36O40 | 80458-29-3 | Details |
Abz-Ala-Phe-Arg-Phe-Ser-Gln-EDDnp trifluoroacetate salt | C50H63N15O13 | 1926163-28-1 | Details |
VIP Antagonist | C154H257N49O40S | 125093-93-8 | Details |
VIP (4-28) (human, mouse, rat) trifluoroacetate salt | C134H221N39O36S | 64326-02-9 | Details |
VIP (3-28) (human, mouse, rat) trifluoroacetate salt | C138H226N40O39S | 115444-33-2 | Details |
(Deamino-Cys1,Lys)-Vasopressin trifluoroacetate salt | C46H64N12O12S2 | 2989-84-6 | Details |
(H-Cys-Phe-OH) (Disulfide bond) | C24H30N4O6S2 | 62130-80-7 | Details |
Ac-Ala-Ser-Thr-Asp-AMC | C26H33N5O11 | 354151-60-3 | Details |
Ac-Ala-Ala-OH | C8H14N2O4 | 19245-87-5 | Details |
Prepro VIP (156-170) (human) | C71H106N16O31 | 107902-86-3 | Details |
(d(CH2)51,Tyr(Et)2,Val4,Arg8)-Vasopressin | C53H77N13O11S2 | 77453-01-1 | Details |
Ac-Ala-Glu-OH | C10H16N2O6 | 57282-74-3 | Details |
(H-Cys-Ala-OH) (Disulfide bond) | C12H22N4O6S2 | 20898-21-9 | Details |
Product Total: Product Page: | ||||
175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 |